跳至主要内容
临床试验/EUCTR2020-002358-26-DE
EUCTR2020-002358-26-DE进行中(未招募)1 期

A randomised, intra-individual controlled trial of the cutaneous healing properties of petrolatum versus the vehicle for Oleogel-S10 when applied topically to mechanically induced partial thickness wounds in healthy volunteers

Amryt Research Ltd.0 个研究点目标入组 16 人开始时间: 2020年7月9日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Adult healthy volunteers aged 18 to 45 years
  • 2. Male or female
  • 3. Sexually active females of childbearing potential must be willing to use an effective form of birth control with failure rates <1% per year (e.g. implant, injectable, combined oral contraceptive, intrauterine contraceptive device, vasectomy or vasectomised partner, sexual abstinence) during participation in the study (and for at least four weeks thereafter)
  • 4. Skin phototype II to III according to the Fitzpatrick classification
  • 5. Body mass index between 18.5 to 29.9 kg/m2 according to World Health Organization
  • 6. Non-smoker
  • 7. Subject has been informed, has read and understood the information/informed consent form, and has given written informed consent
  • 8. Subject must be able and willing to follow study procedures and instructions
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 16
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Pregnant or nursing women
  • 2. SARS-CoV-2 infection is confirmed
  • 3. Positive human immunodeficiency virus, hepatitis B or C serology
  • 4. Known or suspected defect of wound healing
  • 5. Any kind of systemic skin barrier impairment, e.g. atopic dermatitis, psoriasis
  • 6. Scars, tattoos or other skin signs interfering with the study procedures and measurements
  • 7. Sunburn
  • 8. Ultraviolet sessions or sun exposure of the arms planned during the study period
  • 9. Known or suspected hypersensitivity to one of the components of the investigational medicinal products
  • 10. Allergy to Mepilex® Border Lite dressing
  • 11. Any treatment which may affect the blood coagulation and haemostasis (anticoagulant medications, non steroidal anti inflammatory drugs, etc.)
  • 12. Any physical treatment (like laser or surgery) on the arms within the last six months
  • 13. Use of topical or systemic treatments on the investigational areas within four weeks of Day 1 (including but not limited to: topical hyaluronan, anti-inflammatory drugs, corticoids, retinoids, vitamin C) that would interfere with assessment and/or investigational treatments
  • 14. Systemic antibiotics, systemic or topical steroids within two weeks of Day 1
  • 15. History or presence of alcohol or drug abuse within the last two years
  • 16. Medical history of skin cancer
  • 17. Diabetes mellitus
  • 18. Any acute or unstable chronic pathology that may interfere with the study conduct, in the opinion of the investigator including found or suspected active SARS-CoV-2 infection
  • 19. Current participation or participation in a clinical study within 30 days of Day 1
  • 20. Subject is in a dependent relationship (e.g. relative or family member) with the investigator, study site’s staff, or sponsor’s staff
  • 21. Subjects who have been placed in an institution through an official or court order

研究者

相似试验

A clinical trial to assess the effect of petrolatum... | 临床试验